Louis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 15-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 15-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.20 Cr
as on 15-07-2024
- Revenue -57.66%
(FY 2021)
- Profit -2862.07%
(FY 2021)
- Ebitda -122.13%
(FY 2021)
- Net Worth -10.40%
(FY 2021)
- Total Assets 6.15%
(FY 2021)
About Louis Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company has closed loans amounting to ₹4.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kranthi Kumar and Narasimha Bandreddi serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC041958
- Company No.
041958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Louis Pharmaceuticals Private Limited offer?
Louis Pharmaceuticals Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Fatty Esters, Organic and Inorganic Solvents, Aromatic Hydrocarbon Solvent, Industrial Chemicals & Supplies, Aldehydes, Industrial Chemicals, Organic Acid, API (Active Pharmaceutical Ingredients), API Intermediate.
Who are the key members and board of directors at Louis Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kranthi Kumar  | Director | 01-Jul-2019 | Current |
| Narasimha Bandreddi | Director | 07-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Louis Pharmaceuticals.
Louis Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 57.66% decrease. The company also saw a substantial fall in profitability, with a 2862.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Louis Pharmaceuticals?
In 2021, Louis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bnr & Sons Advisory Services Private LimitedActive 7 years 6 months
Narasimha Bandreddi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 30 Dec 2014 | ₹2.00 Cr | Satisfied |
State Bank Of Hyderabad Creation Date: 20 Aug 2009 | ₹2.20 Cr | Satisfied |
How Many Employees Work at Louis Pharmaceuticals?
Louis Pharmaceuticals has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Louis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Louis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
